Virtual reality and endoscopic submucosal dissection: VRESD

  • Research type

    Research Study

  • Full title

    Virtual reality to improve patient experience during endoscopic submucosal resection: a feasibility randomized study

  • IRAS ID

    345381

  • Contact name

    Jasmine Palmer

  • Contact email

    kch-tr.research@nhs.net

  • Sponsor organisation

    King’s College Hospital NHS

  • Clinicaltrials.gov Identifier

    NCT06766162

  • Duration of Study in the UK

    0 years, 5 months, 18 days

  • Research summary

    This study aims to evaluate the feasibility of using Virtual Reality (VR) as a method for pain and anxiety management during Endoscopic Submucosal Dissection (ESD), a procedure used to remove abnormal tissues from the colon and the rectum during colonoscopy. ESD is often associated with discomfort and requires sedation or analgesia, which can have side effects like respiratory and heart function suppression. VR has shown promise in reducing pain and anxiety in various medical settings by immersing patients in a relaxing virtual environment that diverts their attention from the procedure.
    In this study, 40 participants will be randomly assigned to either a VR group or a control group. The VR group will use VR during the ESD procedure, while the control group will receive standard sedation protocols. We will compare the pain and anxiety levels between the two groups, as well as the amount of sedation and analgesia used. Additionally, we will assess the satisfaction levels of both patients and endoscopists.
    The primary goal is to determine if VR can be effectively integrated into ESD procedures to reduce pain and anxiety, potentially leading to wider adoption in clinical practice. If successful, this approach could enhance patient comfort, reduce the need for sedatives, and improve the overall experience of undergoing ESD. This feasibility study will lay the groundwork for a larger, multi-centre trial in the future.
    By exploring this innovative use of VR in medical procedures, we aim to provide a safer, more comfortable alternative to traditional pain management methods, ultimately benefiting patients and healthcare providers alike.

  • REC name

    London - Bromley Research Ethics Committee

  • REC reference

    24/LO/0785

  • Date of REC Opinion

    29 Nov 2024

  • REC opinion

    Further Information Favourable Opinion